Stem Cell Research Boosted By Launch Of Regenerative Medicine

[Guest guest]

Stem Cell Research Boosted By Launch Of Regenerative Medicine Journal

http://www.medicalnewstoday.com/medicalnews.php?newsid=36936

Future Science Group is delighted to announce the launch of its new

journal Regenerative Medicine published under the aegis of Senior

Editor Dr Minger of King's College London. Regenerative

Medicine provides a forum to address the important challenges and

advances in stem cell research and regenerative medicine, delivering

essential information in concise, clear and attractive article

formats. The journal is published by Future Medicine, one of the

Future Science Group companies.

Regenerative Medicine is published bimonthly in print and online

formats and offers review articles, primary research, editorials,

technology reports, interviews, perspectives and a variety of added-

value content. Rigorous peer review and rapid publication ensure that

only the best quality and pertinent research is published in a timely

manner. The electronic version of Regenerative Medicine is available

from the Future Medicine website (www.futuremedicine.com) and from

the Ingenta aggregation service (www.ingentaconnect.com).

Manzotti, Editorial Director of Future Medicine commented; " In

recent years we have seen substantial developments in our knowledge

and understanding of stem cell biology and regenerative medicine.

Nevertheless, in many respects, the field is still in its infancy.

The next few decades will unveil the true potential of this emerging

specialty. Regenerative Medicine will provide a critical overview of

these advances as they unfold and explore their potential relevance

in the clinical setting. "

ABOUT FUTURE SCIENCE GROUP

Future Science Group Ltd, based in London has developed an innovative

publishing portfolio to reflect post-genomic medicine. The sequencing

of the human genome was a colossal milestone in the evolution of

healthcare, with repercussions for all those involved in the

healthcare chain. Through its imprints, Future Medicine and Future

Drugs, Future Science Group Ltd provides healthcare practitioners and

research professionals with a unique source of objective, cutting-

edge information on exciting trends emerging in the light of these

advances. For more information please access www.future-drugs.com and

www.futuremedicine.com.

ABOUT THE LONDON REGENERATIVE MEDICINE NETWORK

The first meeting of the London Regenerative Medicine Network was

held on June 1st 2005. The aim of the Network is to help accelerate

the progression of the world-class stem cell and tissue engineering

research being undertaken in London and its translation into everyday

routine clinical practice. Furthermore, the Network is aimed at

helping create the positive environment required to attract and

retain regenerative medicine stake-holders in the London area. The

Network is a grass-roots, research-led organisation, open to all

involved with the advancement of regenerative medicine including the

wider scientific, clinical, engineering, commercial and regulatory

community. The goal is therefore to facilitate a regular forum where

all the interested parties can meet, exchange information, swap ideas

and form valuable collaborations, thus all benefiting from the vast

pool of talent in and around London.

Senior Editor Dr Minger is Director of the Stem Cell Biology

Laboratory at the Wolfson Centre for Age Related Diseases, King's

College London, UK. He is assisted by an internationally acclaimed

editorial advisory board comprising more than 70 leading experts.

Dr Minger commented; " The field of regenerative medicine and stem

cell biology has become one of the hottest areas in contemporary

science. The launch of Regenerative Medicine, as the pre-eminent,

pioneering, international scientific publication in translational and

cellular medicine is extremely timely. " He continued, " This is the

first international journal devoted to the emerging field of

regenerative medicine and stem cell biology. We have assembled an

outstanding group of scientists as members of the editorial board and

with their help we will publish the most up-to-date research, reviews

scientific and clinical meeting reports, technical updates and

editorials " .

Dr Minger, together with Dr Mason from University College

London, has also recently initiated the London Regenerative Medicine

Network (LRMN). With a membership of over 1300 basic scientists,

clinicians, lawyers, investors and members of the regulatory and

funding bodies, monthly LRMN meetings provide highly active and

collaborative symposium for current research related to regenerative

medicine.

Regenerative Medicine is available now in both print and online

formats. Free trial access to the first issue is available on

request. Applicants should contact Galt, Sales Manager,

Future Science Group at info@... or visit

www.futuremedicine.com.